Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -123,096 | 78,500 | 66,900 | -8,900 | 3,600 |
| Depreciation Amortization | 740 | 63,800 | 48,100 | 32,300 | 15,600 |
| Income taxes - deferred | N/A | -300 | -200 | -300 | -300 |
| Accounts receivable | N/A | -56,100 | -32,300 | -18,800 | 13,300 |
| Accounts payable and accrued liabilities | N/A | 14,700 | 600 | -5,400 | -9,400 |
| Other Working Capital | 481 | -25,200 | -35,200 | -24,500 | -5,900 |
| Other Operating Activity | 513 | 61,200 | 54,300 | 42,500 | -2,600 |
| Operating Cash Flow | $-121,362 | $136,600 | $102,200 | $16,900 | $14,300 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -944 | -28,100 | -21,500 | -13,500 | -6,700 |
| Net Acquisitions | 0 | 7,300 | 11,300 | 11,200 | 12,500 |
| Purchase Of Investment | N/A | -217,200 | -215,300 | -122,500 | N/A |
| Sale Of Investment | N/A | 68,500 | 27,100 | 6,200 | 2,000 |
| Other Investing Activity | -1,562 | 17,000 | 16,300 | 14,200 | 2,300 |
| Investing Cash Flow | $-2,506 | $-152,500 | $-182,100 | $-104,400 | $10,100 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | -200 |
| Debt Repayment | N/A | -700 | -500 | -500 | N/A |
| Other Financing Activity | -24 | -1,600 | -1,600 | -1,500 | -1,500 |
| Financing Cash Flow | $-24 | $-2,300 | $-2,100 | $-2,000 | $-1,700 |
| Exchange Rate Effect | -53 | 800 | -4,300 | 200 | 300 |
| Beginning Cash Position | 262,752 | 535,500 | 535,500 | 535,500 | 535,500 |
| End Cash Position | 138,807 | 518,100 | 449,200 | 446,200 | 558,500 |
| Net Cash Flow | $-123,945 | $-17,400 | $-86,300 | $-89,300 | $23,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | -121,362 | 136,600 | 102,200 | 16,900 | 14,300 |
| Capital Expenditure | N/A | -29,400 | -21,800 | -14,100 | -6,700 |
| Free Cash Flow | -121,362 | 107,200 | 80,400 | 2,800 | 7,600 |